BP802

拉米夫定

British Pharmacopoeia (BP) Reference Standard

• 同義詞: 2′,3′-二脱氧-3′-硫胞苷, 3TC, Epivir, Epivir-HBV, Heptovir, Zeffix
• 經驗公式（希爾表示法）: C₈H₁₁N₃O₃S
• CAS號碼: 134678-17-4
• 分子量：: 229.26
• MDL號碼: MFCD00869739
• 分類程式碼代碼: 12352200
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: lamivudine
• 形狀: solid
• 儲存期限: limited shelf life, expiry date on the label
• 製造商／商標名: BP
• 應用: pharmaceutical
• 格式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2
• InChI: 1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1
• InChI 密鑰: JTEGQNOMFQHVDC-NKWVEPMBSA-N

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Lamivudine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Abacavir, Zidovudine and Lamivudine Tablets

Zidovudine and Lamivudine Tablets

Abacavir and Lamivudine Tablets

Lamivudine Tablets

生化／生理作用

拉米夫定是一种有效的核苷类似物逆转录酶抑制剂（nRTI）。 它是胞苷的类似物，除抑制乙型肝炎的逆转录酶外，还可抑制两种类型（1型和2型）的HIV逆转录酶。它需要磷酸化为其三磷酸形式才具有活性。3TC-三磷酸也抑制细胞DNA聚合酶。

包裝

Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS08
• 訊號詞: Warning
• 危險聲明: H361
• 防範說明: P280
• 危險分類: Repr. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable